Macula Edema Clinical Trial
Official title:
Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
NCT number | NCT04703231 |
Other study ID # | 20201987 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 1, 2020 |
Est. completion date | March 23, 2022 |
Verified date | April 2022 |
Source | Batman Maternity and Child's Health Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
It is aimed to compare the ocular findings in patients with natural and surgical menopause.
Status | Completed |
Enrollment | 60 |
Est. completion date | March 23, 2022 |
Est. primary completion date | March 23, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 45 Years to 65 Years |
Eligibility | Inclusion Criteria: - Newly diagnosed menopause (Natural or Surgical Menopause( At least 3 months after surgery), - No history of illness(Diabetes,Heart disease,Kidney disease etc.) - Not Smoking - Did not use alcohol - Have not use any medication - Age between 45-65 years - BMI between 20-25 kg/m Exclusion Criteria: - Smoking or Alchohol consumption - Age before 45 and after 65 years - Have chronic disease - Using any medication - Have not diagnosed Menopause - BMI greater than 30 kg/m |
Country | Name | City | State |
---|---|---|---|
Turkey | Batman Maternity and Child Health Hospital | Batman |
Lead Sponsor | Collaborator |
---|---|
Batman Maternity and Child's Health Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Macular thickness measurement | Macular thickness(micron) in both eyes will be measured by optical coherence tomography, | 3 months after menopause | |
Primary | Detecting lens opacities | Lens opacities (Grade 1,2,3,4) will be measured by indirect biomicroscopy, | 3 months after menopause | |
Primary | Intraocular pressure measurement | Intraocular pressures( mm Hg) will be measured and recorded with the applanation tonometry device. | 3 months after menopause | |
Primary | Comparison of all detected data | All numerical data will be analyzed and compared with relevant statistical tests and the p value will be accepted as less than 0.05 to be considered a statistically significant difference. | 3 months after menopause |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03321253 -
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
|
N/A | |
Recruiting |
NCT04775849 -
Intraoperative Berger Space Imaging (IBSI)
|
N/A | |
Active, not recruiting |
NCT04120636 -
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
Not yet recruiting |
NCT04977427 -
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
|
Phase 4 | |
Recruiting |
NCT05122702 -
An Innovative Chinese Herbal Formula for Macular Edema
|
Phase 2 | |
Completed |
NCT03363295 -
Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis
|
Phase 4 | |
Completed |
NCT04359771 -
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
|
Phase 4 | |
Completed |
NCT05385562 -
Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
|
N/A | |
Recruiting |
NCT04847869 -
Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema
|
N/A | |
Completed |
NCT03093701 -
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
|
Phase 2 |